Green vaginal discharge: what does the greenish color indicate?

Vaginal discharge is a normal physiologic phenomenon for most people with a vagina. Normal discharge is typically clear to whitish, may vary in texture and volume through the menstrual cycle, and usually has little or no odor. A change in color, consistency, or smell can indicate an alteration of the vaginal environment or an infection that requires medical evaluation. Green-colored vaginal discharge is an abnormal finding that should prompt clinical assessment because it frequently reflects an infectious process. This article reviews the causes, associated symptoms, diagnostic approach, treatment options, and prevention strategies for green vaginal discharge, drawing on guidance from major clinical sources (ACOG, NIH/NIH MedlinePlus, Mayo Clinic, Cleveland Clinic).

Normal vaginal discharge and when color matters

Vaginal discharge originates from cervical and vaginal secretions, exfoliated epithelial cells, and normal vaginal bacteria (predominantly Lactobacillus species). Physiologic discharge:

Varies across the menstrual cycle (increases around ovulation).
Is usually clear or milky white.
Has minimal odor.
Is not associated with pain, burning, fever, or marked itching.

When discharge becomes colored (yellow, green, brown) or is associated with symptoms such as pelvic pain, itching, burning with urination, fever, or postcoital bleeding, the likelihood of infection or inflammation increases and timely evaluation is advisable (ACOG; Mayo Clinic).

A green or greenish-yellow discharge particularly suggests a bacterial or protozoal infection in many cases, but differential diagnosis includes several conditions described below.

Common causes of green vaginal discharge

Several infectious and noninfectious processes can produce green or greenish vaginal discharge. The most frequently implicated causes include:

Trichomoniasis

Etiology: Trichomonas vaginalis, a protozoan parasite.
Clinical features: Frothy, often yellow-green discharge, vaginal irritation or itching, genital discomfort, and dysuria. Symptoms can range from mild to severe; some people are asymptomatic.
Diagnostic testing: Wet mount microscopy may show motile trichomonads; nucleic acid amplification testing (NAAT) is more sensitive and commonly used.
Treatment: Oral metronidazole or tinidazole (single-dose or multi-day regimens). Sexual partners should be treated concurrently to prevent reinfection (NIH; CDC).

Trichomoniasis is one of the most common curable sexually transmitted infections worldwide and is a common cause of greenish discharge.

Gonorrhea (Neisseria gonorrhoeae)

Etiology: Gram-negative diplococcus transmitted by sexual contact.
Clinical features: Copious purulent discharge that can be yellow to green, pelvic pain, dysuria, and intermenstrual bleeding; symptoms may be mild or absent, especially in early infection.
Diagnostic testing: NAAT (recommended specimens: vaginal swab in people with vaginas, endocervical swab, or urine in some settings). Culture may be performed for antibiotic susceptibility testing.
Treatment: Recommended regimens involve injectable ceftriaxone; additional antibiotics are used for possible coinfection with Chlamydia trachomatis based on guidelines (CDC; ACOG).

Gonococcal infections can present with purulent, often green-tinged, discharge and require prompt treatment due to the risk of pelvic inflammatory disease (PID) and complications.

Chlamydia (Chlamydia trachomatis)

Etiology: Intracellular bacterium transmitted sexually.
Clinical features: Can cause mucopurulent discharge that may appear yellowish to green, pelvic or lower abdominal pain, abnormal uterine bleeding, and dysuria. Often asymptomatic.
Diagnostic testing: NAAT is the preferred test.
Treatment: Antibiotics such as doxycycline or azithromycin with partner notification and treatment to prevent reinfection (ACOG; CDC).

Untreated chlamydia can ascend to cause PID and long-term reproductive sequelae.

Pelvic inflammatory disease (PID)

Etiology: Polymicrobial infection of the upper genital tract (endometritis, salpingitis, tubo-ovarian abscess). Common causative organisms include Neisseria gonorrhoeae and Chlamydia trachomatis, but anaerobes and other bacteria can be involved.
Clinical features: Lower abdominal or pelvic pain, fever, cervical motion tenderness, adnexal tenderness, and abnormal vaginal discharge that may be purulent or malodorous and sometimes yellow-green.
Diagnostic testing: Clinical diagnosis supported by laboratory testing (NAAT for gonorrhea/chlamydia), pelvic exam, pregnancy test, and imaging (transvaginal ultrasound) when abscess suspected.
Treatment: Empiric broad-spectrum antibiotics covering likely pathogens, with intravenous therapy for severe cases or hospitalization (ACOG; CDC).

PID is a complication of untreated lower genital tract infections and requires prompt therapy to reduce the risk of infertility, ectopic pregnancy, and chronic pelvic pain.

Cervicitis (non-specific or specific)

Etiology: Inflammation of the endocervix from infections (chlamydia, gonorrhea, trichomonas, Mycoplasma genitalium) or chemical irritation.
Clinical features: Mucopurulent cervical discharge that may be yellowish to green, easy cervical bleeding with contact, and possible pelvic pain.
Diagnostic testing and treatment align with suspected pathogens (NAAT and targeted antibiotics) (ACOG).

Retained foreign body and vaginal foreign objects

Etiology: Retained tampons, contraceptive devices, or other objects can lead to local infection and purulent, sometimes greenish, foul-smelling discharge.
Clinical features: Persistent malodorous discharge, localized pain, and sometimes bleeding.
Management: Removal of the foreign body and local or systemic antibiotics as indicated. Cervical and pelvic examination is essential to identify retained material.

Less common causes and noninfectious contributors

Cellular debris from cervical or vaginal lesions, severe cervical ectropion or erosion with associated infection, and rarely malignancy can produce abnormal discharge.
Antibiotic use, hormonal contraceptive changes, and douching can alter vaginal flora leading to overgrowth of non-Lactobacillus species and abnormal discharge.
Bacterial vaginosis (BV) classically causes thin, grayish discharge with fishy odor and is not typically green; however, mixed infections can produce atypical colors (Mayo Clinic; Cleveland Clinic).

Symptoms that commonly accompany green vaginal discharge

When discharge turns green, it is typically accompanied by at least one of the following:

Vaginal or vulvar itching or irritation.
A strong or unpleasant odor.
Pelvic or lower abdominal pain.
Pain or burning with urination (dysuria).
Pain during sexual activity.
Fever, chills, or malaise (may indicate upper tract infection or systemic involvement).
Abnormal uterine bleeding or postcoital spotting.

The presence and severity of these symptoms help guide urgency of evaluation and empiric therapy.

How clinicians evaluate green vaginal discharge

A systematic approach includes history-taking, physical examination (including pelvic exam), and targeted diagnostic testing.

Medical history

Key points:

Onset, duration, quantity, color, consistency, and odor of the discharge.
Associated symptoms (pain, fever, urinary symptoms, bleeding).
Sexual history (new or multiple partners, condom use, recent partner with STI).
Contraceptive methods including intrauterine devices.
Menstrual history and recent tampon use.
Recent antibiotic use, douching, or topical applications.
Pregnancy status.

Physical and pelvic examination

External genital inspection for erythema, lesions, excoriation, or foreign bodies.
Speculum examination to visualize the cervix and vaginal walls and to assess the character of discharge.
Bimanual examination for uterine or adnexal tenderness suggesting PID or tubo-ovarian abscess.

Laboratory tests

NAAT for Neisseria gonorrhoeae and Chlamydia trachomatis (vaginal swabs are highly sensitive).
Wet mount microscopy: saline preparation may reveal motile Trichomonas organisms or clue cells (suggesting BV); potassium hydroxide (KOH) can be used for whiff test.
Vaginal pH: pH >4.5 can suggest bacterial vaginosis or trichomoniasis.
Culture or NAAT for other organisms if clinically indicated.
Pregnancy test (urine or serum) prior to imaging or antibiotic therapy where relevant.
In suspected PID or systemic infection: CBC, inflammatory markers, and pelvic ultrasound to evaluate for abscess (ACOG; Mayo Clinic).

Accurate diagnosis is important because treatment varies substantially depending on the causative organism(s).

Treatment principles and specific regimens

Treatment should target the identified or most likely pathogens, consider local antibiotic resistance patterns, and follow current clinical guidelines. Management also includes counseling about partner treatment, sexual abstinence until therapy is complete, and follow-up to ensure resolution.

Note: Recommended regimens evolve over time. Clinical decisions should reference current clinical practice guidelines (CDC, ACOG). The following are general recommendations commonly used in practice.

Trichomoniasis

First-line: Metronidazole 2 grams orally in a single dose OR tinidazole 2 grams orally in a single dose. An alternative is metronidazole 500 mg orally twice daily for 7 days.
Partners should be treated simultaneously.
Avoid alcohol during and for 24–72 hours after metronidazole/tinidazole as directed.
Sexual activity should be avoided until therapy is completed and symptoms resolve (NIH; CDC).

Chlamydia

Preferred: Doxycycline 100 mg orally twice daily for 7 days (in non-pregnant patients). Azithromycin 1 g orally single dose has also been used; doxycycline is often preferred because of higher efficacy for rectal infection.
In pregnancy: Azithromycin is preferred because doxycycline is contraindicated.
Sexual partners within the exposure window should be treated (ACOG; CDC).

Gonorrhea

Recommended therapy typically includes a single intramuscular dose of ceftriaxone (dose recommended by current guidelines), with additional treatment for potential chlamydial coinfection (doxycycline). Because of evolving resistance, regimen details should follow the latest CDC and ACOG recommendations.
Test-of-cure and test for other STIs are often recommended in certain circumstances (e.g., persistent symptoms, pharyngeal infection, pregnancy) (CDC; ACOG).

Pelvic inflammatory disease (PID)

Empiric broad-spectrum coverage for likely polymicrobial infection is often initiated when PID is suspected clinically.
Outpatient regimens include an intramuscular dose of a third-generation cephalosporin followed by oral doxycycline with or without metronidazole.
Severe cases, inability to tolerate oral therapy, pregnancy, or suspected tubo-ovarian abscess generally require hospitalization and intravenous antibiotics (ACOG; CDC).

Retained foreign body

Removal of the foreign body is essential.
Local or systemic antibiotics depending on the degree of infection; follow-up to ensure resolution.

Follow-up and test-of-cure

Follow-up evaluations ensure symptom resolution. Test-of-cure NAAT is recommended in pregnancy for some infections and in certain high-risk patients or when there is concern for treatment failure (ACOG; CDC).
For trichomoniasis and gonorrhea, retesting at about 3 months is often advised due to risk of reinfection.

Special considerations

Pregnancy

Many genital infections have implications for pregnancy, including the risk of preterm delivery, low birth weight, and transmission to the neonate.
Safe and effective treatment options differ in pregnancy (for example, doxycycline is contraindicated, and azithromycin is often preferred for chlamydia in pregnancy).
Prompt diagnosis and treatment, and appropriate obstetric follow-up, are important (ACOG; NIH).

Adolescents and young adults

Routine screening recommendations exist for sexually active adolescents and young adults (e.g., screening for chlamydia and gonorrhea in certain age groups), as asymptomatic infections are common and can have long-term consequences (ACOG; CDC).

Antibiotic resistance

Antimicrobial resistance patterns (particularly for Neisseria gonorrhoeae) are changing; culture and sensitivity testing may be indicated when treatment failure is suspected or when local resistance is a concern (CDC).

Potential complications if left untreated

Untreated infections that cause green discharge can lead to significant sequelae:

Pelvic inflammatory disease with risk of infertility and ectopic pregnancy.
Chronic pelvic pain.
Increased susceptibility to other sexually transmitted infections, including HIV.
Pregnancy complications including preterm birth and neonatal infections.
Local abscess formation and systemic infection in severe cases.

Early recognition and treatment reduce these risks.

Prevention strategies

Primary prevention focuses on reducing exposure to sexually transmitted pathogens and maintaining healthy vaginal flora:

Use barrier protection (condoms) consistently during sexual activity to reduce risk of sexually transmitted infections.
Routine STI screening and prompt treatment of partners when an STI is diagnosed.
Avoid douching and unnecessary intravaginal products that disrupt normal flora.
Remove tampons or other intravaginal objects promptly and avoid prolonged retention.
Vaccination when appropriate (e.g., HPV vaccination) to reduce risk of certain genital tract diseases (ACOG; Mayo Clinic).
Education about signs and symptoms that warrant evaluation.

Self-care, home remedies, and what to avoid

Do not attempt to self-diagnose or rely solely on over-the-counter antifungal agents if the discharge is green or accompanied by pain, fever, or urinary symptoms. Antifungal agents treat yeast infections and will not treat bacterial or protozoal infections.
Avoid douching and unverified "vaginal cleanses." These can worsen or predispose to infection (Mayo Clinic; Cleveland Clinic).
Do not delay seeking medical care if you have green discharge with systemic symptoms or severe pelvic pain.
Follow prescribed treatment instructions precisely, complete the full course of antibiotics when given, and ensure sexual partners are evaluated and treated as advised.

When to seek urgent care

Seek prompt medical attention if any of the following occur:

High fever, severe lower abdominal or pelvic pain.
Fainting, severe dizziness, or signs of systemic infection.
Heavy vaginal bleeding or sudden worsening of symptoms.
Symptoms during pregnancy (any abnormal discharge during pregnancy warrants immediate attention).
Inability to tolerate oral intake or oral medications due to vomiting or other reasons.

Clinical examples and likely diagnoses

Yellow-green, frothy discharge with marked vaginal itching and a positive wet mount: Trichomoniasis is likely.
Profuse, purulent, greenish discharge with pelvic pain and a positive NAAT for gonorrhea: Gonorrhea is likely.
Mild mucoid to purulent discharge, positive NAAT for Chlamydia trachomatis: Chlamydial cervicitis is likely.
Foul-smelling discharge after prolonged tampon use: Consider retained foreign body with secondary infection.
Diffuse lower abdominal pain, fever, cervical motion tenderness, and abnormal discharge: Empiric treatment for PID is indicated while diagnostic testing is performed.

Clinical judgment and laboratory testing are necessary to distinguish among these possibilities.

Summary and key messages

Green vaginal discharge is an abnormal finding and commonly indicates infection, most often by organisms such as Trichomonas vaginalis, Neisseria gonorrhoeae, Chlamydia trachomatis, or mixed pelvic infection.
Associated symptoms (pain, fever, dysuria, foul odor) and patient history (sexual contacts, tampon retention, pregnancy) guide urgency and testing.
Accurate diagnosis typically requires pelvic examination and laboratory testing (NAAT, wet mount, pH, and, when indicated, culture or ultrasound).
Treatment is organism-specific; prompt therapy, partner notification, and abstinence during treatment reduce transmission and complications.
Prevention includes safer sexual practices, avoiding douching, timely removal of intravaginal products, and regular screening when indicated.

If you notice green or otherwise abnormal vaginal discharge, arrange timely evaluation with a qualified healthcare professional for diagnosis and appropriate management.

Sources and clinical references

American College of Obstetricians and Gynecologists (ACOG). Clinical guidance on sexually transmitted infections and pelvic inflammatory disease. https://www.acog.org
National Institutes of Health (MedlinePlus). Vaginal discharge. https://medlineplus.gov/vaginaldischarge.html
Mayo Clinic. Vaginal discharge: when to see a doctor. https://www.mayoclinic.org
Cleveland Clinic. Abnormal vaginal discharge. https://my.clevelandclinic.org
Centers for Disease Control and Prevention (CDC). Sexually transmitted infection treatment guidelines. https://www.cdc.gov/std/treatment-guidelines/